Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis

Table 5 C-indexes for the Nomogram and FIGO stage systems in patients with cNET

Survival		Training cohort	P	Internal validation cohort	P	External validation cohort	P
Overall survival	Nomogram	0.787 (95%CI, 0.765–0.808)	< 0.001	0.789 (95%CI, 0.764–0.822)	< 0.005	0.761 (95%CI, 0.702–0.819)	< 0.001
Overall survival	FIGO stage	0.711 (95%CI, 0.685–0.736	< 0.001	0.724 (95%CI, 0.684–0.763)	< 0.005	0.723 (95%CI, 0.664–0.781)	< 0.001
Cancer -specific surviva	Nomogram	0.784 (95%CI, 0.758–0.809)	< 0.001	0.798 (95%CI, 0.758–0.837)	< 0.005	0.770 (95%CI, 0.707–0.832)	< 0.001
Cancer -specific surviva	FIGO stage	0.709 (95%CI, 0.681–0.736)	< 0.001	0.734 (95%CI, 0.691–0.773)	< 0.005	0.737 (95%CI, 0.674–0.799)	< 0.001

CI confidence interval, FIGO the International Federation of Gynecology and Obstetrics

ISSN: 1471-2407